Susquehanna Fundamental Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56,408	Closed	-$916K	–	472
2025 Q4	$916K	Hold	56,408	–	–	0.03%	359
2025 Q3	$844K	Sell	56,408 -3,483	-6%	-$42.4K	0.03%	362
2025 Q2	$698K	Sell	59,891 -34,276	-36%	-$311K	0.02%	503
2025 Q1	$700K	Buy	94,167 +56,408	+149%	+$434K	0.01%	768
2024 Q4	$226K	Buy	+37,759	New	+$208K	﹤0.01%	986
2024 Q2	$124K	Buy	34,276 +12,180	+55%	+$38.7K	﹤0.01%	884
2024 Q1	$70.9K	Buy	+22,096	New	+$85.5K	﹤0.01%	660
2023 Q4	–	Sell	-43,389	Closed	-$236K	–	77
2023 Q3	$236K	Sell	43,389 -46,090	-52%	-$305K	0.02%	316
2023 Q2	$600K	Sell	89,479 -12,962	-13%	-$96.4K	0.02%	417
2023 Q1	$905K	Hold	102,441	–	–	0.02%	541
2022 Q4	$783K	Buy	+102,441	New	+$797K	0.01%	730

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna Fundamental Investments's ADPT Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 56,408 shares — an estimated $916K sold.

Susquehanna Fundamental Investments first reported a position in ADPT in Q4 2022 and held it in 11 quarters. The position peaked at $916K in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Susquehanna Fundamental Investments reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
Susquehanna Fundamental Investments sold 56,408 Adaptive Biotechnologies shares in Q1 2026, an estimated $916K.
Susquehanna Fundamental Investments first reported a position in Adaptive Biotechnologies in Q4 2022 and held it in 11 quarters.
Susquehanna Fundamental Investments's Adaptive Biotechnologies position peaked at $916K in Q4 2025.
295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.